

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.02819478 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.25791882 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25791882 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92378287 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 4.83729297 |
| 6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.70602905 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.49945148 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49945148 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 4.43159957 |
| 10 | mature B cell differentiation (GO:0002335) | 4.20952254 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.04461362 |
| 12 | mature B cell differentiation involved in immune response (GO:0002313) | 4.00006698 |
| 13 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86846812 |
| 14 | growth hormone receptor signaling pathway (GO:0060396) | 3.79279906 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.62512385 |
| 16 | oxaloacetate metabolic process (GO:0006107) | 3.60479734 |
| 17 | T-helper 1 type immune response (GO:0042088) | 3.53251697 |
| 18 | valine metabolic process (GO:0006573) | 3.52192381 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50897793 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 3.50218146 |
| 21 | cellular response to growth hormone stimulus (GO:0071378) | 3.47677088 |
| 22 | negative regulation of granulocyte differentiation (GO:0030853) | 3.45498264 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43086597 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.39430352 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.37539117 |
| 26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37126686 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36188235 |
| 28 | oxidative demethylation (GO:0070989) | 3.30967048 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.27557179 |
| 30 | DNA deamination (GO:0045006) | 3.22619922 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.19226197 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.13718484 |
| 33 | myeloid dendritic cell differentiation (GO:0043011) | 3.13581003 |
| 34 | tricarboxylic acid metabolic process (GO:0072350) | 3.05053330 |
| 35 | myeloid dendritic cell activation (GO:0001773) | 3.03492774 |
| 36 | negative regulation of myotube differentiation (GO:0010832) | 3.03233646 |
| 37 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97010279 |
| 38 | DNA demethylation (GO:0080111) | 2.95856757 |
| 39 | regulation of granulocyte differentiation (GO:0030852) | 2.93898501 |
| 40 | viral protein processing (GO:0019082) | 2.92483490 |
| 41 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.89304028 |
| 42 | serine transport (GO:0032329) | 2.87132682 |
| 43 | NADH metabolic process (GO:0006734) | 2.85215862 |
| 44 | germinal center formation (GO:0002467) | 2.82577598 |
| 45 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.82327882 |
| 46 | dendritic cell differentiation (GO:0097028) | 2.81035392 |
| 47 | regulation of monocyte differentiation (GO:0045655) | 2.78359667 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 2.76162984 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75122591 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 2.74981315 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.74981315 |
| 52 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.73973989 |
| 53 | positive regulation of cholesterol efflux (GO:0010875) | 2.73037482 |
| 54 | activation of MAPKKK activity (GO:0000185) | 2.72404198 |
| 55 | positive regulation of histone deacetylation (GO:0031065) | 2.71271111 |
| 56 | sexual reproduction (GO:0019953) | 2.71216465 |
| 57 | response to interferon-beta (GO:0035456) | 2.65518468 |
| 58 | peroxisomal transport (GO:0043574) | 2.65247970 |
| 59 | regulation of cholesterol efflux (GO:0010874) | 2.65107969 |
| 60 | defense response to protozoan (GO:0042832) | 2.64614895 |
| 61 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.64391070 |
| 62 | type I interferon signaling pathway (GO:0060337) | 2.63082569 |
| 63 | cellular response to type I interferon (GO:0071357) | 2.63082569 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 2.62918788 |
| 65 | cellular response to zinc ion (GO:0071294) | 2.62837558 |
| 66 | response to type I interferon (GO:0034340) | 2.59959368 |
| 67 | pyrimidine nucleoside salvage (GO:0043097) | 2.59149238 |
| 68 | pyrimidine-containing compound salvage (GO:0008655) | 2.59149238 |
| 69 | modulation by symbiont of host defense response (GO:0052031) | 2.58277339 |
| 70 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.58277339 |
| 71 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.58277339 |
| 72 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.58277339 |
| 73 | modulation by symbiont of host immune response (GO:0052553) | 2.58277339 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 2.58277339 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.57970368 |
| 76 | amyloid precursor protein catabolic process (GO:0042987) | 2.57877481 |
| 77 | mannose metabolic process (GO:0006013) | 2.56964663 |
| 78 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.56754886 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 2.55792749 |
| 80 | regulation of ARF protein signal transduction (GO:0032012) | 2.55121284 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.54779632 |
| 82 | viral transcription (GO:0019083) | 2.54709081 |
| 83 | mitochondrial calcium ion transport (GO:0006851) | 2.52970523 |
| 84 | negative regulation of innate immune response (GO:0045824) | 2.52235411 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.50484113 |
| 86 | signal complex assembly (GO:0007172) | 2.50480095 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.50181257 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 2.49848431 |
| 89 | barbed-end actin filament capping (GO:0051016) | 2.49126026 |
| 90 | Peyers patch development (GO:0048541) | 2.48509767 |
| 91 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.48509767 |
| 92 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47482621 |
| 93 | branched-chain amino acid metabolic process (GO:0009081) | 2.47154239 |
| 94 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.46980637 |
| 95 | protein targeting to peroxisome (GO:0006625) | 2.46935654 |
| 96 | establishment of protein localization to peroxisome (GO:0072663) | 2.46935654 |
| 97 | protein localization to peroxisome (GO:0072662) | 2.46935654 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.46795207 |
| 99 | thymic T cell selection (GO:0045061) | 2.44470694 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43096209 |
| 101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43063051 |
| 102 | positive regulation of granulocyte differentiation (GO:0030854) | 2.42906215 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.42684325 |
| 104 | phospholipid efflux (GO:0033700) | 2.42656156 |
| 105 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.42554013 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.42263061 |
| 107 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.41993917 |
| 108 | DNA dealkylation (GO:0035510) | 2.40893655 |
| 109 | regulation of relaxation of muscle (GO:1901077) | 2.40778642 |
| 110 | regulation of apoptotic cell clearance (GO:2000425) | 2.40556488 |
| 111 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.40201880 |
| 112 | metallo-sulfur cluster assembly (GO:0031163) | 2.38677757 |
| 113 | iron-sulfur cluster assembly (GO:0016226) | 2.38677757 |
| 114 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37822112 |
| 115 | cellular response to interferon-beta (GO:0035458) | 2.35663951 |
| 116 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.34589100 |
| 117 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34541195 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.34118856 |
| 119 | L-phenylalanine catabolic process (GO:0006559) | 2.34118856 |
| 120 | positive regulation of B cell proliferation (GO:0030890) | 2.33616993 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 2.33379777 |
| 122 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.32913953 |
| 123 | negative thymic T cell selection (GO:0045060) | 2.32747289 |
| 124 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.29562208 |
| 125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26981635 |
| 126 | detection of bacterium (GO:0016045) | 2.26502238 |
| 127 | negative regulation of type 2 immune response (GO:0002829) | 2.24884627 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.24582901 |
| 129 | synaptic vesicle exocytosis (GO:0016079) | 2.22247321 |
| 130 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.20728196 |
| 131 | regulation of type 2 immune response (GO:0002828) | 2.19067107 |
| 132 | response to peptidoglycan (GO:0032494) | 2.18822977 |
| 133 | cellular response to virus (GO:0098586) | 2.17662541 |
| 134 | positive regulation of type 2 immune response (GO:0002830) | 2.17304179 |
| 135 | detection of other organism (GO:0098543) | 2.14735087 |
| 136 | tolerance induction (GO:0002507) | 2.14496608 |
| 137 | T cell selection (GO:0045058) | 2.13720587 |
| 138 | negative regulation of T cell mediated immunity (GO:0002710) | 2.13700531 |
| 139 | modulation by symbiont of host cellular process (GO:0044068) | 2.11406347 |
| 140 | positive regulation of synapse maturation (GO:0090129) | 2.11232499 |
| 141 | positive regulation of protein deacetylation (GO:0090312) | 2.08476586 |
| 142 | regulation of extracellular matrix disassembly (GO:0010715) | 2.08467817 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.08237418 |
| 144 | creatine metabolic process (GO:0006600) | 2.08077136 |
| 145 | regulation of mast cell degranulation (GO:0043304) | 2.05738362 |
| 146 | modulation by virus of host process (GO:0019054) | 2.04446584 |
| 147 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.04410293 |
| 148 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.04410293 |
| 149 | regulation of defense response to virus by virus (GO:0050690) | 2.03402961 |
| 150 | positive regulation of protein dephosphorylation (GO:0035307) | 1.99142436 |
| 151 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.98990493 |
| 152 | regulation of Rap GTPase activity (GO:0032317) | 1.98820703 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 1.98042974 |
| 154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.97491947 |
| 155 | negative regulation of cell size (GO:0045792) | 1.96784591 |
| 156 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 1.96521254 |
| 157 | leukocyte aggregation (GO:0070486) | 1.96394525 |
| 158 | regulation of T cell tolerance induction (GO:0002664) | 1.96094153 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 1.95951391 |
| 160 | virion attachment to host cell (GO:0019062) | 1.95951391 |
| 161 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 1.95305585 |
| 162 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 1.94156895 |
| 163 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 1.93205181 |
| 164 | positive regulation of receptor recycling (GO:0001921) | 1.91599033 |
| 165 | synaptic vesicle maturation (GO:0016188) | 1.90166621 |
| 166 | positive regulation of CREB transcription factor activity (GO:0032793) | 1.90003527 |
| 167 | regulation of histone deacetylation (GO:0031063) | 1.89932059 |
| 168 | response to protozoan (GO:0001562) | 1.89742040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56245424 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.00628925 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95426048 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72351338 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70556913 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69251462 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.61967028 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42587105 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.41529305 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38819569 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30027683 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24335460 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20920322 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15874509 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.15852137 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14305445 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11806361 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10310269 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09955604 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05276788 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01231441 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00245850 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.97957516 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90315828 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.90088871 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.85041295 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84567569 |
| 28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.82373129 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.81188763 |
| 30 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.80740886 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79174962 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78716529 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77475215 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77113615 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.75074971 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71537581 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70266579 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68559775 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68243018 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67697874 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67551164 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66010737 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64949907 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.63699962 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63049715 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62423327 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62163856 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.60370674 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60060397 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56761380 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55489535 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55169952 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55143860 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53702248 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53221238 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52429256 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.51057579 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49685615 |
| 59 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49499968 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49409740 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48983734 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47221336 |
| 63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47163915 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.46511894 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46438258 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45763594 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44411640 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42414405 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42363751 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39967564 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39707103 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36298904 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.35383624 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35357115 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34605644 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34283083 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.33751385 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33141296 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32851350 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31992931 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29303753 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28638310 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.28093648 |
| 84 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27472759 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27141021 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27074923 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26846717 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25880789 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25594373 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24826984 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24634378 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24058750 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23067724 |
| 94 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23013700 |
| 95 | MYB_26560356_Chip-Seq_TH1_Human | 1.21757627 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21630203 |
| 97 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21444313 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20847802 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20637737 |
| 100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20564547 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17180919 |
| 102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16776205 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15769887 |
| 104 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15697455 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15571745 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15397065 |
| 107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.13871094 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12638056 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11432682 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11396106 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11204829 |
| 112 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11131172 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10805535 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09705569 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08993090 |
| 116 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07862294 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07328880 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07321904 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07217707 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06703640 |
| 121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06245463 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 1.06229230 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05817079 |
| 124 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05734496 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04218906 |
| 126 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03644334 |
| 127 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03241166 |
| 128 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02558926 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02330091 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01412402 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00194833 |
| 132 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00143934 |
| 133 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00083867 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99930681 |
| 135 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99683942 |
| 136 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99586013 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98462372 |
| 138 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98177885 |
| 139 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97545317 |
| 140 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97428776 |
| 141 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97065701 |
| 142 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96582123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 4.99658666 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.00437358 |
| 3 | MP0000685_abnormal_immune_system | 3.84544213 |
| 4 | MP0002254_reproductive_system_inflammat | 3.33782848 |
| 5 | MP0005671_abnormal_response_to | 2.93478258 |
| 6 | MP0001790_abnormal_immune_system | 2.83799260 |
| 7 | MP0005387_immune_system_phenotype | 2.83799260 |
| 8 | MP0009840_abnormal_foam_cell | 2.74975198 |
| 9 | MP0001800_abnormal_humoral_immune | 2.68298782 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.44172361 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.40188936 |
| 12 | MP0004510_myositis | 2.31473694 |
| 13 | MP0001348_abnormal_lacrimal_gland | 2.26641071 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.25081075 |
| 15 | MP0002723_abnormal_immune_serum | 2.15763622 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.06735567 |
| 17 | MP0001873_stomach_inflammation | 2.01313565 |
| 18 | MP0002420_abnormal_adaptive_immunity | 1.99249663 |
| 19 | MP0001819_abnormal_immune_cell | 1.98332188 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 1.95166558 |
| 21 | MP0002419_abnormal_innate_immunity | 1.94684995 |
| 22 | MP0005451_abnormal_body_composition | 1.94636162 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.89547825 |
| 24 | MP0005025_abnormal_response_to | 1.88376174 |
| 25 | MP0005365_abnormal_bile_salt | 1.88195485 |
| 26 | MP0003329_amyloid_beta_deposits | 1.87856413 |
| 27 | MP0003879_abnormal_hair_cell | 1.86967802 |
| 28 | MP0003436_decreased_susceptibility_to | 1.84476853 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.81754850 |
| 30 | MP0000751_myopathy | 1.79152466 |
| 31 | MP0009785_altered_susceptibility_to | 1.77537660 |
| 32 | MP0003690_abnormal_glial_cell | 1.76619049 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.75714107 |
| 34 | MP0005083_abnormal_biliary_tract | 1.71117573 |
| 35 | MP0004858_abnormal_nervous_system | 1.69573164 |
| 36 | MP0002398_abnormal_bone_marrow | 1.69301417 |
| 37 | MP0005310_abnormal_salivary_gland | 1.69176912 |
| 38 | MP0000716_abnormal_immune_system | 1.65474739 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.63488292 |
| 40 | MP0004947_skin_inflammation | 1.63303517 |
| 41 | MP0000604_amyloidosis | 1.60984110 |
| 42 | MP0009278_abnormal_bone_marrow | 1.57690402 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.55349043 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.54684097 |
| 45 | MP0008260_abnormal_autophagy | 1.53310442 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.52940991 |
| 47 | MP0003303_peritoneal_inflammation | 1.47976494 |
| 48 | MP0004130_abnormal_muscle_cell | 1.47956888 |
| 49 | MP0003075_altered_response_to | 1.46918584 |
| 50 | MP0002722_abnormal_immune_system | 1.45016195 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.43975937 |
| 52 | MP0002429_abnormal_blood_cell | 1.43516513 |
| 53 | MP0001853_heart_inflammation | 1.40720870 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.39902813 |
| 55 | MP0003866_abnormal_defecation | 1.36488338 |
| 56 | MP0000749_muscle_degeneration | 1.33941679 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.31866260 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.28925081 |
| 59 | MP0001764_abnormal_homeostasis | 1.27290183 |
| 60 | MP0003724_increased_susceptibility_to | 1.26394014 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.26375317 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.25153832 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.24579334 |
| 64 | MP0008469_abnormal_protein_level | 1.24212073 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.23387831 |
| 66 | MP0008569_lethality_at_weaning | 1.22162307 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.21740858 |
| 68 | MP0003279_aneurysm | 1.21301984 |
| 69 | MP0001958_emphysema | 1.20486642 |
| 70 | MP0000920_abnormal_myelination | 1.20050638 |
| 71 | MP0008874_decreased_physiological_sensi | 1.16512216 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.16443628 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.13309796 |
| 74 | MP0009764_decreased_sensitivity_to | 1.13054462 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.12923561 |
| 76 | MP0000747_muscle_weakness | 1.12724243 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 1.09360095 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.08114228 |
| 79 | MP0005332_abnormal_amino_acid | 1.07709731 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07647517 |
| 81 | MP0005670_abnormal_white_adipose | 1.07484424 |
| 82 | MP0003045_fibrosis | 1.07316765 |
| 83 | MP0010329_abnormal_lipoprotein_level | 1.07095698 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.05626581 |
| 85 | MP0002405_respiratory_system_inflammati | 1.02892552 |
| 86 | MP0000013_abnormal_adipose_tissue | 1.02049853 |
| 87 | MP0005166_decreased_susceptibility_to | 1.00149633 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 0.99802234 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.98840950 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.95945611 |
| 91 | MP0006082_CNS_inflammation | 0.94751295 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.94502713 |
| 93 | MP0002064_seizures | 0.94278971 |
| 94 | MP0000343_altered_response_to | 0.92494527 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.91056726 |
| 96 | MP0005390_skeleton_phenotype | 0.91004230 |
| 97 | MP0001270_distended_abdomen | 0.90965509 |
| 98 | MP0002132_abnormal_respiratory_system | 0.90774727 |
| 99 | MP0003646_muscle_fatigue | 0.90348099 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.89176566 |
| 101 | MP0002933_joint_inflammation | 0.89102099 |
| 102 | MP0005535_abnormal_body_temperature | 0.88430710 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.87573122 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.87448436 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.86156743 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.86127611 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.85363851 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.84389091 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.83725923 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.83684233 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.83583217 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.80383902 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.80383902 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.79287239 |
| 115 | MP0000609_abnormal_liver_physiology | 0.78063721 |
| 116 | MP0001663_abnormal_digestive_system | 0.77265367 |
| 117 | MP0003011_delayed_dark_adaptation | 0.76254834 |
| 118 | MP0000858_altered_metastatic_potential | 0.74429869 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.74147572 |
| 120 | MP0004270_analgesia | 0.74129820 |
| 121 | MP0002106_abnormal_muscle_physiology | 0.72381393 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.71926137 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.70885053 |
| 124 | MP0005334_abnormal_fat_pad | 0.70868086 |
| 125 | MP0001542_abnormal_bone_strength | 0.69356958 |
| 126 | MP0000249_abnormal_blood_vessel | 0.68966350 |
| 127 | MP0003091_abnormal_cell_migration | 0.68614467 |
| 128 | MP0000598_abnormal_liver_morphology | 0.68277852 |
| 129 | MP0009763_increased_sensitivity_to | 0.67760592 |
| 130 | MP0002822_catalepsy | 0.67547979 |
| 131 | MP0003959_abnormal_lean_body | 0.67462929 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.67440967 |
| 133 | MP0003828_pulmonary_edema | 0.67375174 |
| 134 | MP0001970_abnormal_pain_threshold | 0.66746884 |
| 135 | MP0009745_abnormal_behavioral_response | 0.66642939 |
| 136 | MP0002971_abnormal_brown_adipose | 0.66568189 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.65972743 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.65933509 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.65909958 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.65801540 |
| 141 | MP0002653_abnormal_ependyma_morphology | 0.65630064 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.65184782 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.63873953 |
| 144 | MP0004142_abnormal_muscle_tone | 0.63166801 |
| 145 | MP0004808_abnormal_hematopoietic_stem | 0.63121809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ragged-red muscle fibers (HP:0003200) | 4.04725040 |
| 2 | Agammaglobulinemia (HP:0004432) | 3.99062378 |
| 3 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.89679741 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.89679741 |
| 5 | Facial diplegia (HP:0001349) | 3.81279413 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.70476481 |
| 7 | Progressive inability to walk (HP:0002505) | 3.56297825 |
| 8 | Chronic otitis media (HP:0000389) | 3.51152399 |
| 9 | Thrombocytosis (HP:0001894) | 3.46877504 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 3.36302033 |
| 11 | Failure to thrive in infancy (HP:0001531) | 3.09132888 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.08789601 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08596126 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.04687002 |
| 15 | Fatigue (HP:0012378) | 3.04205679 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 3.03464890 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 2.95314172 |
| 18 | Inflammation of the large intestine (HP:0002037) | 2.94235361 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 2.87871541 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.87537468 |
| 21 | Recurrent bronchitis (HP:0002837) | 2.84790273 |
| 22 | Myositis (HP:0100614) | 2.81352586 |
| 23 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.80096423 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 2.79052023 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 2.78353823 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75836223 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 2.75247274 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.73498494 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72926677 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72926677 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72926677 |
| 32 | Abnormality of binocular vision (HP:0011514) | 2.72017492 |
| 33 | Diplopia (HP:0000651) | 2.72017492 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.71230500 |
| 35 | Orchitis (HP:0100796) | 2.70709673 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.70316522 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69946422 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69946422 |
| 39 | Colitis (HP:0002583) | 2.65420277 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62251668 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60894566 |
| 42 | Poikiloderma (HP:0001029) | 2.59947951 |
| 43 | Recurrent viral infections (HP:0004429) | 2.59656572 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59287051 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57495464 |
| 46 | Increased connective tissue (HP:0009025) | 2.51066941 |
| 47 | Recurrent skin infections (HP:0001581) | 2.42332598 |
| 48 | Emphysema (HP:0002097) | 2.42262361 |
| 49 | Epistaxis (HP:0000421) | 2.41089267 |
| 50 | Ankle clonus (HP:0011448) | 2.40483543 |
| 51 | Chronic sinusitis (HP:0011109) | 2.39734398 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.39221856 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.37508307 |
| 54 | Stomatitis (HP:0010280) | 2.37214019 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.35650466 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.34798341 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.33922747 |
| 58 | Petechiae (HP:0000967) | 2.33489071 |
| 59 | Cellulitis (HP:0100658) | 2.31349211 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.30266943 |
| 61 | Loss of speech (HP:0002371) | 2.30045993 |
| 62 | Nasal polyposis (HP:0100582) | 2.29011062 |
| 63 | Optic neuritis (HP:0100653) | 2.26858317 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.26858317 |
| 65 | Myopathic facies (HP:0002058) | 2.25916458 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25836842 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25836842 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25836842 |
| 69 | Neutropenia (HP:0001875) | 2.24142358 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.23883085 |
| 71 | Axonal loss (HP:0003447) | 2.23175265 |
| 72 | Stridor (HP:0010307) | 2.20589089 |
| 73 | Aplastic anemia (HP:0001915) | 2.20198799 |
| 74 | Opisthotonus (HP:0002179) | 2.17714965 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.17714240 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17148487 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 2.16962601 |
| 78 | Polycythemia (HP:0001901) | 2.16331396 |
| 79 | Easy fatigability (HP:0003388) | 2.15812592 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 2.15613035 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.15131351 |
| 82 | Bulbar palsy (HP:0001283) | 2.14672051 |
| 83 | Round ear (HP:0100830) | 2.14502192 |
| 84 | Late onset (HP:0003584) | 2.13734309 |
| 85 | Gingivitis (HP:0000230) | 2.12041170 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11117943 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.10767259 |
| 88 | Hyperacusis (HP:0010780) | 2.10601402 |
| 89 | J-shaped sella turcica (HP:0002680) | 2.10355588 |
| 90 | Lymphopenia (HP:0001888) | 2.07424038 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.05759535 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 2.04274103 |
| 93 | Ulnar deviation of the wrist (HP:0003049) | 2.04015478 |
| 94 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.03424885 |
| 95 | Difficulty running (HP:0009046) | 2.03339673 |
| 96 | Mucopolysacchariduria (HP:0008155) | 2.03211204 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03211204 |
| 98 | Abnormality of DNA repair (HP:0003254) | 2.03198545 |
| 99 | Restrictive lung disease (HP:0002091) | 2.03098523 |
| 100 | IgM deficiency (HP:0002850) | 2.03009965 |
| 101 | Oligomenorrhea (HP:0000876) | 2.02258560 |
| 102 | Purpura (HP:0000979) | 2.02123344 |
| 103 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01117346 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00717779 |
| 105 | Visual hallucinations (HP:0002367) | 2.00632837 |
| 106 | Amyloidosis (HP:0011034) | 2.00237647 |
| 107 | Nemaline bodies (HP:0003798) | 1.99932024 |
| 108 | Brushfield spots (HP:0001088) | 1.99908392 |
| 109 | Cerebral aneurysm (HP:0004944) | 1.99261207 |
| 110 | Cerebral palsy (HP:0100021) | 1.99198403 |
| 111 | Papilledema (HP:0001085) | 1.98259422 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.97054820 |
| 113 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96744629 |
| 114 | Meningitis (HP:0001287) | 1.96615447 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 1.93955430 |
| 116 | Prolonged neonatal jaundice (HP:0006579) | 1.92974564 |
| 117 | Hyperlipoproteinemia (HP:0010980) | 1.92303266 |
| 118 | Increased cerebral lipofuscin (HP:0011813) | 1.91977885 |
| 119 | Glomerulonephritis (HP:0000099) | 1.91797611 |
| 120 | Upper limb amyotrophy (HP:0009129) | 1.91502881 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.91502881 |
| 122 | Rapidly progressive (HP:0003678) | 1.91387204 |
| 123 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91385818 |
| 124 | Pustule (HP:0200039) | 1.90905251 |
| 125 | Recurrent abscess formation (HP:0002722) | 1.90029338 |
| 126 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89618238 |
| 127 | Ketosis (HP:0001946) | 1.88624494 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.88469496 |
| 129 | B lymphocytopenia (HP:0010976) | 1.88469496 |
| 130 | Eczematoid dermatitis (HP:0000976) | 1.88019960 |
| 131 | EMG: neuropathic changes (HP:0003445) | 1.87818795 |
| 132 | Verrucae (HP:0200043) | 1.87549241 |
| 133 | Papilloma (HP:0012740) | 1.87549241 |
| 134 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87295627 |
| 135 | Increased muscle lipid content (HP:0009058) | 1.86510725 |
| 136 | Gingival bleeding (HP:0000225) | 1.86314774 |
| 137 | Diaphragmatic weakness (HP:0009113) | 1.85783735 |
| 138 | Hypoplasia of the thymus (HP:0000778) | 1.85427999 |
| 139 | Mutism (HP:0002300) | 1.84835094 |
| 140 | Hypercortisolism (HP:0001578) | 1.84724768 |
| 141 | Pulmonary infiltrates (HP:0002113) | 1.84516875 |
| 142 | Obstructive lung disease (HP:0006536) | 1.84422186 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84422186 |
| 144 | Achilles tendon contracture (HP:0001771) | 1.83538896 |
| 145 | Increased IgE level (HP:0003212) | 1.83120163 |
| 146 | Death in childhood (HP:0003819) | 1.83006194 |
| 147 | EMG: myopathic abnormalities (HP:0003458) | 1.82875342 |
| 148 | Annular pancreas (HP:0001734) | 1.82312363 |
| 149 | Asymmetric septal hypertrophy (HP:0001670) | 1.82007369 |
| 150 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81599149 |
| 151 | Onion bulb formation (HP:0003383) | 1.81300910 |
| 152 | Vasculitis (HP:0002633) | 1.81189235 |
| 153 | Inability to walk (HP:0002540) | 1.78888277 |
| 154 | Autoimmune thrombocytopenia (HP:0001973) | 1.78468459 |
| 155 | Weak cry (HP:0001612) | 1.76431211 |
| 156 | Increased serum ferritin (HP:0003281) | 1.75915835 |
| 157 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75212303 |
| 158 | Congenital stationary night blindness (HP:0007642) | 1.74828387 |
| 159 | Chest pain (HP:0100749) | 1.73896498 |
| 160 | Periodontitis (HP:0000704) | 1.73857192 |
| 161 | Homocystinuria (HP:0002156) | 1.73541109 |
| 162 | Abnormality of homocysteine metabolism (HP:0010919) | 1.73541109 |
| 163 | Albinism (HP:0001022) | 1.73317484 |
| 164 | Joint stiffness (HP:0001387) | 1.72578340 |
| 165 | Polygenic inheritance (HP:0010982) | 1.72482750 |
| 166 | Tetraparesis (HP:0002273) | 1.71495382 |
| 167 | Increased IgM level (HP:0003496) | 1.71255955 |
| 168 | Abnormal number of erythroid precursors (HP:0012131) | 1.71126376 |
| 169 | Xanthomatosis (HP:0000991) | 1.70918915 |
| 170 | Thin bony cortex (HP:0002753) | 1.70545083 |
| 171 | Pallor (HP:0000980) | 1.70483539 |
| 172 | Recurrent sinusitis (HP:0011108) | 1.69923089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.46673100 |
| 2 | MAP3K14 | 2.70276441 |
| 3 | BCKDK | 2.64919614 |
| 4 | TBK1 | 2.57442764 |
| 5 | BLK | 2.38843445 |
| 6 | RIPK4 | 2.29569001 |
| 7 | INSRR | 2.28323121 |
| 8 | TYK2 | 2.27775123 |
| 9 | PRPF4B | 2.27213373 |
| 10 | FGFR4 | 2.17107082 |
| 11 | SIK3 | 2.14652889 |
| 12 | IKBKB | 2.07146312 |
| 13 | KIT | 2.07023564 |
| 14 | ERN1 | 2.06757424 |
| 15 | TRIB3 | 2.05257048 |
| 16 | IKBKE | 2.01057331 |
| 17 | MAP3K13 | 1.83199043 |
| 18 | JAK3 | 1.82673501 |
| 19 | FLT3 | 1.80045428 |
| 20 | TLK1 | 1.76789087 |
| 21 | TGFBR2 | 1.76146989 |
| 22 | PINK1 | 1.74610387 |
| 23 | SRPK1 | 1.72645437 |
| 24 | IRAK4 | 1.68653822 |
| 25 | MAP3K7 | 1.65447152 |
| 26 | IRAK3 | 1.64103375 |
| 27 | SIK1 | 1.58182269 |
| 28 | DAPK2 | 1.55912429 |
| 29 | CDC42BPA | 1.46351080 |
| 30 | MAPK15 | 1.45960363 |
| 31 | CHUK | 1.45339425 |
| 32 | CSF1R | 1.43276970 |
| 33 | JAK1 | 1.41363215 |
| 34 | BTK | 1.41201148 |
| 35 | EPHB1 | 1.39445076 |
| 36 | STK16 | 1.37238078 |
| 37 | IRAK1 | 1.36480366 |
| 38 | SMG1 | 1.35233032 |
| 39 | TAOK2 | 1.35185468 |
| 40 | CAMKK1 | 1.34440064 |
| 41 | ZAP70 | 1.34340370 |
| 42 | SYK | 1.33663699 |
| 43 | TAOK1 | 1.33527936 |
| 44 | TSSK6 | 1.33439916 |
| 45 | IRAK2 | 1.24661141 |
| 46 | DYRK1B | 1.21249049 |
| 47 | NME2 | 1.20926930 |
| 48 | MAP2K2 | 1.17362907 |
| 49 | PKN1 | 1.16746946 |
| 50 | CSK | 1.12312333 |
| 51 | BRD4 | 1.11648361 |
| 52 | TYRO3 | 1.06152838 |
| 53 | MAP3K1 | 1.05130455 |
| 54 | PHKG2 | 1.02562041 |
| 55 | PHKG1 | 1.02562041 |
| 56 | TESK1 | 1.02182880 |
| 57 | PRKCH | 1.01766647 |
| 58 | TGFBR1 | 1.01236141 |
| 59 | GRK6 | 0.99310143 |
| 60 | RIPK1 | 0.94928919 |
| 61 | PRKD3 | 0.92962352 |
| 62 | TAOK3 | 0.92482627 |
| 63 | MATK | 0.89806134 |
| 64 | HIPK2 | 0.89786917 |
| 65 | EPHA3 | 0.89455507 |
| 66 | PIK3CG | 0.88092878 |
| 67 | PAK6 | 0.87834251 |
| 68 | JAK2 | 0.87411477 |
| 69 | TNK2 | 0.86602536 |
| 70 | MAP3K3 | 0.86187504 |
| 71 | NEK9 | 0.84931948 |
| 72 | PRKD2 | 0.83259763 |
| 73 | PDPK1 | 0.83075080 |
| 74 | DAPK3 | 0.81659979 |
| 75 | SIK2 | 0.80621351 |
| 76 | MAP3K10 | 0.80544703 |
| 77 | MAP3K11 | 0.79644409 |
| 78 | ARAF | 0.77684348 |
| 79 | NTRK3 | 0.76215642 |
| 80 | PRKAA2 | 0.75540732 |
| 81 | DDR2 | 0.75213248 |
| 82 | MAP2K6 | 0.74065183 |
| 83 | CAMK4 | 0.73681516 |
| 84 | PDK1 | 0.73089603 |
| 85 | FES | 0.72546382 |
| 86 | PIM2 | 0.72048570 |
| 87 | MAPK12 | 0.71968301 |
| 88 | PKN2 | 0.71841129 |
| 89 | MAP3K6 | 0.70139070 |
| 90 | RPS6KA2 | 0.67779318 |
| 91 | MARK2 | 0.66768922 |
| 92 | RPS6KA6 | 0.66316848 |
| 93 | STK38 | 0.65787916 |
| 94 | HCK | 0.64691215 |
| 95 | MAPK7 | 0.64331347 |
| 96 | CLK1 | 0.64041193 |
| 97 | DYRK3 | 0.63871767 |
| 98 | TESK2 | 0.63854778 |
| 99 | KSR2 | 0.63307103 |
| 100 | FGFR3 | 0.63289151 |
| 101 | OBSCN | 0.62819329 |
| 102 | PASK | 0.61448253 |
| 103 | FGR | 0.61446439 |
| 104 | MAPKAPK3 | 0.60801407 |
| 105 | PIM1 | 0.59039837 |
| 106 | LYN | 0.58865799 |
| 107 | MAP2K3 | 0.57106891 |
| 108 | CASK | 0.57099381 |
| 109 | LCK | 0.56230062 |
| 110 | MAPK11 | 0.55415097 |
| 111 | BMX | 0.55076017 |
| 112 | EPHA4 | 0.54397555 |
| 113 | CAMK1 | 0.54047185 |
| 114 | GRK1 | 0.53721012 |
| 115 | RPS6KC1 | 0.53224670 |
| 116 | RPS6KL1 | 0.53224670 |
| 117 | PTK6 | 0.51950913 |
| 118 | LIMK1 | 0.51307247 |
| 119 | ITK | 0.50888983 |
| 120 | AKT2 | 0.50667068 |
| 121 | MUSK | 0.50306206 |
| 122 | MAPK4 | 0.48632982 |
| 123 | CDK19 | 0.46968841 |
| 124 | UHMK1 | 0.46303353 |
| 125 | EEF2K | 0.46177892 |
| 126 | FYN | 0.45025902 |
| 127 | CAMK1D | 0.44763170 |
| 128 | PRKD1 | 0.44291166 |
| 129 | RPS6KA4 | 0.44235386 |
| 130 | MAPKAPK2 | 0.44005203 |
| 131 | BUB1 | 0.41641469 |
| 132 | TIE1 | 0.41350069 |
| 133 | TTN | 0.41173777 |
| 134 | TXK | 0.40985095 |
| 135 | ICK | 0.40538854 |
| 136 | MYLK | 0.39692979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.87901755 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.92650269 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.91651232 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52615695 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48338995 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.23087106 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18623792 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15157409 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98856923 |
| 10 | ABC transporters_Homo sapiens_hsa02010 | 1.90571859 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90507461 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85460519 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80208962 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72307772 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70406729 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68110240 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.67863526 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.66816424 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.55808124 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.53814262 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49279677 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46580800 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43872565 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42244620 |
| 25 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.38635042 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.35384268 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30655555 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29935806 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.29761226 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.29636221 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28058062 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.25787139 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.23363647 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23223626 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.21761328 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20626968 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19064936 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18981929 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15544685 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14565002 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13627598 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12523807 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07990310 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07887419 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05431585 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.04967686 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04452826 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04134920 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03010023 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02990460 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01329369 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98466328 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98092034 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98053200 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97331094 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97282814 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97021657 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.94732048 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92450182 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92019642 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91489346 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89676235 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88944044 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.88926544 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88887062 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88632161 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85986694 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.85968022 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85477031 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85302330 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84875294 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84436146 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83530270 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81475942 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81060363 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.81035987 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80954662 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79474411 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.78004325 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77154084 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76602122 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76506859 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.75813875 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75487632 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75252824 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75206670 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75105088 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74423984 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73596345 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71107704 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70863348 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70852631 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70472350 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69912191 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.69790451 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69729238 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.67835513 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.67310485 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67229111 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67148241 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66975308 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66908298 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.66825775 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66509617 |
| 105 | Morphine addiction_Homo sapiens_hsa05032 | 0.65787537 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65374571 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65329927 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65072022 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.64796864 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64472918 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.64000959 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63706454 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62819038 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62397000 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61761085 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61575855 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60919402 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60900110 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60288941 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60262207 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60194227 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59966551 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.59754233 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.59243181 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58821903 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58181185 |
| 127 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58171368 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57163735 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.56662173 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56130340 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56024220 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.55762243 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55675185 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55192890 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.54833733 |
| 136 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53183032 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52938729 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52006400 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51302516 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50978015 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.50628497 |
| 142 | Shigellosis_Homo sapiens_hsa05131 | 0.49525412 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48772815 |
| 144 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48687810 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48175612 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.47510671 |
| 147 | Allograft rejection_Homo sapiens_hsa05330 | 0.47216412 |
| 148 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47142037 |
| 149 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44372098 |
| 150 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43719627 |
| 151 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41979002 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41357483 |
| 153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41019813 |

